Daniel E. Owens - 09 Mar 2023 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Human Resources Officer
Signature
Lisa Taylor as Attorney-in-fact for Dan Owens
Issuer symbol
TMCI
Transactions as of
09 Mar 2023
Net transactions value
-$10,033
Form type
4
Filing time
10 Mar 2023, 20:00:18 UTC
Previous filing
02 Dec 2022
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale $10,033 -411 -3.8% $24.41 10,289 09 Mar 2023 Direct F1, F2
transaction TMCI Common Stock Award $0 +20,625 +200% $0.000000 30,914 10 Mar 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option Right to Buy Award $0 +46,750 $0.000000 46,750 10 Mar 2023 Stock Option Right to Buy 46,750 $24.07 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Daniel E. Owens is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 Includes 5,025 RSUs.
F3 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F4 Includes 25,650 RSUs.
F5 The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.